Key result
Recalibrating standard CVD risk algorithms drops high-risk classifications by ~30% and equalizes performance.
Why the study?
Does systematic recalibration of cardiovascular risk algorithms improve risk estimation and targeting of preventive therapy in individuals without baseline CVD?
Meta-Analysis (n=360,737)
Yes
Does systematic recalibration of cardiovascular risk algorithms improve risk estimation and targeting of preventive therapy in individuals without baseline CVD?
Systematic recalibration of widely used CVD risk algorithms equalizes their performance and improves the targeting of preventive statin therapy.
AIMS: There is debate about the optimum algorithm for cardiovascular disease (CVD) risk estimation. We conducted head-to-head comparisons of four algorithms recommended by primary prevention guidelines, before and after 'recalibration', a method that adapts risk algorithms to take account of differences in the risk characteristics of the populations being studied. METHODS AND RESULTS: Using individual-participant data on 360 737 participants without CVD at baseline in 86 prospective studies from 22 countries, we compared the Framingham risk score (FRS), Systematic COronary Risk Evaluation (SCORE), pooled cohort equations (PCE), and Reynolds risk score (RRS). We calculated measures of risk discrimination and calibration, and modelled clinical implications of initiating statin therapy in people judged to be at 'high' 10 year CVD risk. Original risk algorithms were recalibrated using the risk factor profile and CVD incidence of target populations. The four algorithms had similar risk discrimination. Before recalibration, FRS, SCORE, and PCE over-predicted CVD risk on average by 10%, 52%, and 41%, respectively, whereas RRS under-predicted by 10%. Original versions of algorithms classified 29-39% of individuals aged ≥40 years as high risk. By contrast, recalibration reduced this proportion to 22-24% for every algorithm. We estimated that to prevent one CVD event, it would be necessary to initiate statin therapy in 44-51 such individuals using original algorithms, in contrast to 37-39 individuals with recalibrated algorithms. CONCLUSION: Before recalibration, the clinical performance of four widely used CVD risk algorithms varied substantially. By contrast, simple recalibration nearly equalized their performance and improved modelled targeting of preventive action to clinical need.
No takes yet. Share an insight, caveat, or question.
Pennells et al. (2018) conducted a meta-analysis in Cardiovascular disease risk estimation (n=360,737). Recalibrated cardiovascular risk algorithms (FRS, SCORE, PCE, RRS) vs. Original cardiovascular risk algorithms was evaluated on Proportion of individuals classified as high 10-year CVD risk. Recalibration of four widely used CVD risk algorithms reduced the proportion of individuals classified as high risk from 29-39% to 22-24%, nearly equalizing their performance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: